Joseph DeFranco, MS, is a Graduate Fellow, Program in Biodefense, Schar School of Policy and Government, George Mason University, Arlington, VA. Maureen Rhemann, PhD, is a Visiting Scholar, O'Neill-Pellegrino Program in Brain Science, Global Law and Policy, Georgetown University, Washington, DC. James Giordano, PhD, MPhil, is Professor, Departments of Neurology and Biochemistry, and Chief, Neuroethics Studies Program, Georgetown University Medical Center, Washington, DC; and a Senior Fellow, Project in Biosecurity, Technology, and Ethics, US Naval War College, Newport, RI.
Health Secur. 2020 Jul/Aug;18(4):267-277. doi: 10.1089/hs.2020.0009.
Neuroscience and neurotechnology (neuroS/T) are techniques and tools used to assess or affect the nervous system. Current and near-future developments are enabling an expanding palette of capabilities to understand and influence brain functions that can foster wellbeing and economic growth. This "neurobioeconomy" is rapidly growing, attributable in large part to the global dissemination of knowledge that fosters and contributes to scientific innovation, invention, and commercialization. As a result, several countries have initiated programs in brain research and innovation. Not all brain sciences engender security concerns, but a predominance in global biomedical, bioengineering, wellness/lifestyle, and defense markets enables considerable power. Such power can be leveraged in nonkinetic or kinetic domains, and several countries have identified neuroS/T as viable and of growing value for use in warfare, intelligence, and national security operations. In addition to the current focus on biotechnology, the United States and its allies must acknowledge the significance of brain science and its projected impact on the economy, national security, and lifestyles. In this article, we examine growth of the neuroS/T market, discuss how the neurobioeconomy poses distinct ethical and security issues for the broader bioeconomy, provide examples of such issues that arise from specific nation-state activity and technological commercialization, and propose a risk assessment and mitigation approach that can be engaged by the economic, scientific, and security communities.
神经科学和神经技术(neuroS/T)是用于评估或影响神经系统的技术和工具。当前和近期的发展使人们能够扩大理解和影响大脑功能的能力,从而促进福祉和经济增长。这种“神经生物经济”正在迅速发展,在很大程度上归因于知识的全球传播,这些知识促进和有助于科学创新、发明和商业化。因此,一些国家已经启动了脑研究和创新计划。并非所有的脑科学都会引发安全问题,但在全球生物医学、生物工程、健康/生活方式和国防市场中的主导地位赋予了相当大的权力。这种力量可以在非动能或动能领域中发挥作用,一些国家已经将 neuroS/T 确定为在战争、情报和国家安全行动中可行且具有日益增长价值的技术。除了当前对生物技术的关注外,美国及其盟国必须认识到脑科学及其对经济、国家安全和生活方式的预期影响的重要性。在本文中,我们研究了 neuroS/T 市场的增长,讨论了神经生物经济如何对更广泛的生物经济带来独特的伦理和安全问题,提供了特定国家活动和技术商业化引发的此类问题的例子,并提出了一种风险评估和缓解方法,经济、科学和安全界可以参与其中。